Quick answer: IGF-1 DES is a truncated analog of insulin-like growth factor 1 (IGF-1), specifically IGF-1 DES(1-3), which means it is the IGF-1 molecule with the first three amino acids removed. It is studied in laboratory and animal models.
IGF-1 DES turns up in growth factor research discussions, often confused with the other IGF-1 variants that sit near it. If you are sourcing it for laboratory work, the confusion is the part to clear up first. What you want is a plain description of what it is and a way to confirm the vial matches the label.
Here is the grounded version. IGF-1 DES is a truncated analog, and that truncation is the whole distinction.
What IGF-1 DES actually is
IGF-1 DES is a truncated analog of insulin-like growth factor 1, usually shortened to IGF-1. The fuller name is IGF-1 DES(1-3), which points straight at the modification. It is the IGF-1 molecule with the first three amino acids removed from one end. So it is a shortened variant of the natural growth factor rather than a separate compound.
That structure is what groups it with the IGF-1 research peptides. When a source describes IGF-1 DES, the accurate description is structural. It is a truncated IGF-1 analog studied in laboratory models.
According to the published literature, IGF-1 DES has been studied in laboratory and animal models of growth factor signaling. Those findings describe activity observed in that setting. They have not been confirmed as human effects. For sourcing, the useful facts are the truncated structure and the documentation on the vial.
Why the truncation matters in research
Where a molecule is modified shapes how it gets studied. Because IGF-1 DES is missing the first three residues of IGF-1, it sits inside the slice of growth factor literature that compares the native molecule to its analogs.
That truncation is the defining feature of the compound. If you are sourcing it, the identity a Certificate of Analysis should confirm is the specific analog, at the stated purity, on your lot.
How IGF-1 DES compares to IGF-1 LR3
The variant researchers most often set beside it is IGF-1 LR3, which is a different modified analog of the same parent molecule. We cover it in our look at what IGF-1 LR3 is. IGF-1 DES is defined by a removed segment, while IGF-1 LR3 is defined by added and substituted structure.
Those comparisons are structural maps. They describe how the analogs differ on paper, not what any of them do in a body.
Sourcing IGF-1 DES the careful way
Here is where a lot of buyers get burned. A short peptide is easy to put in a vial and impossible to verify by eye. Documentation is what protects you.
Look for a per batch Certificate of Analysis you can see before you buy, HPLC verified purity on the specific lot, mass spectrometry confirmation of identity, and a lot number tied to your vial. You can see a live Certificate of Analysis so you know what real documentation looks like. If a source cannot show you that, walk away.
The 2026 vendor shakeout made this the whole ballgame. Several large suppliers closed, some without refunds, and mislabeled product filled some of the gaps. A COA tied to your specific lot is what separates a compound you can study from a mystery vial.
The short version
Peptide Hackers carries IGF-1 DES with a Certificate of Analysis on every batch, HPLC verified purity of ninety nine percent or higher, and mass spectrometry confirmation. Researchers in Los Angeles and Orange County can order online and pick up the same day in person, with shipping available if you prefer delivery. The full catalog is at peptidehackers.com.
Confirm the paperwork, then the peptide.
All products are for laboratory research only. Not for human or veterinary use.
Research Use Only
This article is provided for educational purposes. All peptides discussed are sold for research use only and are not intended for human consumption or therapeutic use.